Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

187

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N05AX12	ZALONIL	G	Aripiprazole - 10mg	10mg	Tablet, orodispersible	1,988,887 L.L
N05AX12	ABIPREX 15	G	Aripiprazole - 15mg	15mg	Tablet	1,075,074 L.L
N05AX12	ATYPRAL	G	Aripiprazole - 15mg	15mg	Tablet	712,237 L.L
N05AX12	JOSWE ARIPAL 15	G	Aripiprazole - 15mg	15mg	Tablet	2,413,541 L.L
N05AX12	PIRIFY	G	Aripiprazole - 15mg	15mg	Tablet	795,555 L.L
N05AX12	XALIPRO	G	Aripiprazole - 15mg	15mg	Tablet	2,418,917 L.L
N05AX12	ZALONIL	G	Aripiprazole - 15mg	15mg	Tablet, orodispersible	2,426,980 L.L
N05AX12	JOSWE ARIPAL 30	G	Aripiprazole - 30mg	30mg	Tablet	4,687,323 L.L
N05AX12	ABILIFY MAINTENA	B	Aripiprazole - 400mg	400mg	Injectable powder for suspension, prolonged release+solvent	29,491,998 L.L
N05AX12	JOSWE ARIPAL 5	G	Aripiprazole - 5mg	5mg	Tablet	1,389,533 L.L
N05AX12	PIRIFY	G	Aripiprazole - 5mg	5mg	Tablet	614,328 L.L
N05AX12	XALIPRO	G	Aripiprazole - 5mg	5mg	Tablet	1,746,995 L.L
N01BB58	ORABLOC	G	Articaine HCl - 4%, Epinephrine (tartrate) - 1/100.000		Injectable solution	2,308,721 L.L
N01BB58	ARTINIBSA 4% WITH EPINEPHRINE 1/100000	B	Articaine HCl - 4%, Epinephrine - 1/100.000		Injectable solution	1,968,729 L.L
N01BB58	ARTICAINE MEDIS ADRENALINE	G	Articaine HCl - 40mg/ml, Adrenaline - 0.07mg/ml		Injectable solution	1,881,380 L.L
N01BB58	SEPTANEST ADRENALINEE	B	Articaine HCl - 72mg/1.8ml, Adrenaline (tartrate) - 0.033mg/1.8ml	1/100,000	Injectable solution	2,945,703 L.L
A11GA01	REDOXON EFF.ORANGE	B	Ascorbic acid (vit C) - 1g	1g	Tablet, effervescent	366,869 L.L
A11GA01	VITAMIN C S.A.L.F.	G	Ascorbic acid (vit C) - 500mg/5ml	500mg/5ml	Injectable solution	498,566 L.L
A11AA	COMPLEVIT	G	Ascorbic acid - 1.32g, Riboflavine - 0.018g, Nicotinamide - 0.264g, Cyanocobalamine - 0.9g, Pyridoxine HCl - 0.132g, Thiamine mononitrate - 0.288g, Iron Ammonium Citrate - 3.6g		Syrup	218,854 L.L
L01XX02	SPECTRILA	BioTech	Asparaginase, recombinant - 10,000IU	10,000IU	Injectable powder for concentrate for solution	21,370,813 L.L
C07AB03	TENORMIN	B	Atenolol - 100mg	100mg	Tablet, film coated	279,519 L.L
C07AB03	ATONIUM	G	Atenolol - 100mg	100mg	Tablet	461,207 L.L
C07AB03	BLOKIUM 100MG	G	Atenolol - 100mg	100mg	Tablet	377,620 L.L
C07AB03	TENORMIN	B	Atenolol - 50mg	50mg	Tablet, film coated	393,746 L.L
C07AB03	APO-ATENOL	G	Atenolol - 50mg	50mg	Tablet	327,898 L.L
C07AB03	ATENOLOL BIOGARAN	G	Atenolol - 50mg	50mg	Tablet, scored	295,645 L.L
C07AB03	ATONIUM	G	Atenolol - 50mg	50mg	Tablet	239,588 L.L
C07AB03	BLOKIUM 50MG	G	Atenolol - 50mg	50mg	Tablet	186,794 L.L
L01FF05	TECENTRIQ	BioTech	Atezolizumab - 1200mg	1200mg	Injectable concentrate for solution	L.L
L01FF05	TECENTRIQ	BioTech	Atezolizumab - 1200mg	1200mg	Injectable concentrate for solution	375,054,619 L.L

...

187